GSK3B and Cowden syndrome 1: ARHGAP10 variant A inhibits epithelial–mesenchymal transition (EMT) by suppressing the PI3K/AKT/GSK3β (glycogen synthase kinase 3 beta) pathway; however, the role of variant B in CS remains unclear [212].